GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 80 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $321 | +33.2% | 167 | 0.0% | 0.00% | – |
Q2 2023 | $241 | -31.3% | 167 | 0.0% | 0.00% | – |
Q1 2023 | $351 | +85.7% | 167 | 0.0% | 0.00% | – |
Q4 2022 | $189 | – | 167 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 167 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 167 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 167 | 0.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 167 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 167 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | – | 167 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 167 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 167 | 0.0% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 167 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | – | 167 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 167 | 0.0% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 167 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 167 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 167 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 167 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | – | 167 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 167 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
Virtu Financial LLC | 14,683 | $32,000 | 0.00% |